MRKR Marker Therapeutics, Inc.
Fundamentals / CIK 0001094038 / USDMarker Therapeutics, Inc. reported $3.55M in revenue and a net loss of $8.55M for the fiscal year ended December 31, 2025 (down 46.2% year over year), with a -264.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MRKR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$3.55M -46.2% YoY
-
Operating Income FY 2025-$9.36M -264.0% margin
-
Net Income FY 2025-$8.55M -241.2% net margin
-
Diluted EPS FY 2025-$0.44 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$9.04M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55M | $6.59M | $3.31M | $3.51M | $0 | $500K | $213K | $206K | $183K | -- |
| Research & Development | $11.80M | $13.47M | $10.42M | $11.97M | $27.79M | $18.88M | $12.76M | $7.95M | $5.25M | $3.80M |
| Total Operating Expenses | $16.44M | $17.71M | $17.89M | $23.30M | $40.72M | $29.35M | $22.74M | $148.4M | $11.66M | $8.49M |
| Operating Income | -$12.89M | -$11.12M | -$14.58M | -$19.79M | -$39.48M | -$28.89M | -$22.53M | -$148.2M | -$11.48M | -$8.49M |
| EBITDA | -- | -- | -- | -$17.00M | -$37.33M | -$28.40M | -$22.42M | -- | -- | -- |
| Interest Income | $594K | $437K | $539K | $248K | $5.7K | $149K | $1.08M | $254K | $0 | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -$12.18M | -$10.68M | -$14.04M | -$19.78M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | -$15K | $50K | $3.7K | -- | -- | -- | -- | $0 | $0 | $0 |
| Net Income | -$12.16M | -$10.73M | -$8.24M | -$29.93M | -$41.88M | -$28.71M | -$21.43M | -$148.0M | -$10.98M | -$2.46M |
| Basic EPS | -$0.79 | -$1.19 | -$0.94 | -$3.58 | -$5.47 | -$6.10 | -$4.70 | -$77.50 | -$11.60 | -$3.60 |
| Diluted EPS | -$0.79 | -$1.19 | -$0.94 | -$3.58 | -$5.47 | -$6.10 | -$4.70 | -$77.50 | -$11.60 | -$7.20 |
| Basic Shares Outstanding | 15.3M | 9.0M | 8.8M | 8.4M | 7.7M | 4.7M | 4.6M | 1.9M | 945.3K | 689.0K |
| Diluted Shares Outstanding | 15.3M | 9.0M | 8.8M | 8.4M | 7.7M | 4.7M | 4.6M | 1.9M | 945.3K | 742.1K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | $752K | $1.10M | $1.23M | $861K | $349K | $2.25M |
| Research & Development | $2.17M | $1.48M | $2.84M | $2.14M | $2.35M | $4.18M | $3.14M | $5.09M |
| Total Operating Expenses | $3.23M | $2.62M | $4.07M | $2.99M | $3.37M | $5.12M | $4.96M | $6.11M |
| Operating Income | -$3.23M | -$2.62M | -$4.07M | $559K | -$3.37M | -$5.12M | -$4.96M | -$3.86M |
| Interest Income | $92K | $113K | $133K | $166K | $138K | $128K | $162K | $74K |
| Net Income | -$1.84M | -$1.83M | -$3.18M | -$1.70M | -$2.00M | -$4.02M | -$4.45M | -$3.84M |
| Basic EPS | -$0.10 | -$0.09 | -$0.16 | -- | -$0.12 | -$0.29 | -$0.40 | -- |
| Diluted EPS | -$0.10 | -$0.09 | -$0.16 | -- | -$0.12 | -$0.29 | -$0.40 | -- |
| Basic Shares Outstanding | 19.3M | 19.3M | 19.3M | -- | 16.8M | 14.0M | 11.1M | -- |
| Diluted Shares Outstanding | 19.3M | 19.3M | 19.3M | -- | 16.8M | 14.0M | 11.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $16.07M | $19.19M | $15.11M | $11.78M | $42.35M | $21.35M | $43.90M | $61.75M | $5.13M | $7.85M |
| Cash & Short-Term Investments | $16.07M | $19.19M | $15.11M | $11.78M | $42.35M | $21.35M | $43.90M | $61.75M | $5.13M | $7.85M |
| Other Current Assets | -- | $2.0K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $19.07M | $22.02M | $17.13M | $16.62M | $45.98M | $24.41M | $45.49M | $62.00M | $5.18M | $7.92M |
| Property, Plant & Equipment, Net | -- | -- | -- | $12.32M | $12.32M | $10.36M | $418K | $148K | $0 | -- |
| Total Non-Current Assets | $0 | $0 | $0 | $17.80M | $22.15M | $21.20M | $873K | $148K | $0 | $0 |
| Total Assets | $19.07M | $22.02M | $17.13M | $34.42M | $68.14M | $45.61M | $46.36M | $62.14M | $5.18M | $7.92M |
| Accounts Payable | $794K | $1.07M | $961K | $1.10M | $5.14M | $2.94M | $993K | $1.62M | $1.01M | $680K |
| Deferred Revenue (Current) | $975K | -- | -- | $0 | $1.15M | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | $1.71M | $1.33M | -- | -- | -- | -- | -- | $0 | $492K |
| Total Current Liabilities | $2.27M | $3.46M | $3.07M | $7.78M | $12.90M | $6.40M | $1.99M | $2.80M | $1.52M | $1.74M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $7.04M | $11.25M | $11.87M | $280K | $0 | $0 | $0 |
| Total Liabilities | $2.27M | $3.46M | $3.07M | $14.82M | $24.15M | $18.27M | $2.27M | $2.80M | $1.52M | $1.74M |
| Total Debt (incl. Leases) | -- | -- | -- | $7.62M | $11.90M | $12.26M | $484K | -- | -- | -- |
| Common Stock | $17K | $11K | $8.9K | $8.4K | $8.3K | $51K | $46K | $45K | $11K | $8.4K |
| Retained Earnings | -$459.2M | -$447.0M | -$436.3M | -$428.0M | -$398.1M | -$356.2M | -$327.5M | -$306.1M | -$157.4M | -$145.8M |
| Total Stockholders' Equity | $16.80M | $18.56M | $14.05M | $19.60M | $43.99M | $27.34M | $44.09M | $59.34M | $3.66M | $6.18M |
| Total Equity | $16.80M | $18.56M | $14.05M | $19.60M | $43.99M | $27.34M | $44.09M | $59.34M | $3.66M | $6.18M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $9.04M | $11.33M | $14.92M | $16.07M | $17.59M | $10.46M | $13.69M | $19.19M |
| Cash & Short-Term Investments | $9.04M | $11.33M | $14.92M | $16.07M | $17.59M | $10.46M | $13.69M | $19.19M |
| Other Current Assets | -- | $7.2K | $13K | -- | -- | -- | -- | $2.0K |
| Total Current Assets | $12.50M | $14.59M | $17.43M | $19.07M | $21.73M | $14.77M | $16.99M | $22.02M |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $12.50M | $14.59M | $17.43M | $19.07M | $21.73M | $14.77M | $16.99M | $22.02M |
| Accounts Payable | $867K | $585K | $1.50M | $794K | $951K | $1.72M | $1.30M | $1.07M |
| Deferred Revenue (Current) | -- | -- | -- | $975K | $1.35M | $1.35M | -- | -- |
| Other Current Liabilities | $244K | $805K | $1.00M | -- | $328K | $657K | $411K | $1.71M |
| Total Current Liabilities | $2.00M | $2.42M | $3.64M | $2.27M | $3.35M | $4.28M | $2.50M | $3.46M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.00M | $2.42M | $3.64M | $2.27M | $3.35M | $4.28M | $2.50M | $3.46M |
| Common Stock | $17K | $17K | $17K | $17K | $17K | $11K | $11K | $11K |
| Retained Earnings | -$466.0M | -$464.2M | -$462.4M | -$459.2M | -$457.5M | -$455.5M | -$451.5M | -$447.0M |
| Total Stockholders' Equity | $10.50M | $12.17M | $13.80M | $16.80M | $18.39M | $10.49M | $14.49M | $18.56M |
| Total Equity | $10.50M | $12.17M | $13.80M | $16.80M | $18.39M | $10.49M | $14.49M | $18.56M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$12.16M | -$10.73M | -$8.24M | -$29.93M | -$41.88M | -$28.71M | -$21.43M | -$148.0M | -$10.98M | -$2.46M |
| Depreciation & Amortization | -- | -- | -- | $2.79M | $2.15M | $486K | $105K | -- | -- | -- |
| Stock-Based Compensation | $538K | $246K | $858K | $3.30M | $5.96M | $5.23M | $5.36M | $16.35M | $2.74M | $1.56M |
| Operating Cash Flow | -$12.01M | -$10.91M | -$16.44M | -$26.97M | -$27.28M | -$20.03M | -$18.28M | -$14.48M | -$8.44M | -$6.51M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -$375K | -$148K | $0 | -- |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -$18.66M | -$14.63M | -$8.44M | -- |
| Investing Cash Flow | -- | -- | $18.66M | -$4.95M | -$3.13M | -$9.25M | -$375K | -$148K | $0 | -- |
| Common Stock Issued | $9.86M | $14.93M | $1.01M | $202K | $52.55M | $6.19M | $0 | -- | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$72K | -$310K | $0 |
| Financing Cash Flow | $9.86M | $14.99M | $1.11M | $202K | $52.56M | $6.74M | $816K | $71.25M | $5.72M | $7.78M |
| Net Change in Cash | -$2.15M | $4.08M | $3.33M | $11.80M | $43.50M | -$22.55M | -$17.84M | $56.62M | -- | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.84M | -$1.83M | -$3.18M | -$1.70M | -$2.00M | -$4.02M | -$4.45M | -$3.84M |
| Stock-Based Compensation | $182K | $196K | $178K | $111K | $33K | $14K | $379K | $51K |
| Operating Cash Flow | -$2.49M | -$3.72M | -$1.40M | -$1.90M | -$2.74M | -$1.88M | -$5.50M | -$4.70M |
| Financing Cash Flow | -- | -- | -- | $0 | $9.86M | $100 | $505 | $14.90M |
| Net Change in Cash | -$2.49M | -$3.72M | -$1.40M | -$1.90M | $7.13M | -$1.88M | -$5.50M | $10.19M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -363.5% | -168.7% | -440.4% | -563.3% | -- | -5777.2% | -10567.3% | -71930.1% | -6271.1% | -- |
| Net Profit Margin | -343.0% | -162.8% | -248.8% | -851.9% | -- | -5741.2% | -10050.9% | -71826.3% | -5999.1% | -- |
| Return on Equity (ROE) | -72.4% | -57.8% | -58.6% | -152.7% | -95.2% | -105.0% | -48.6% | -249.3% | -300.2% | -39.7% |
| Return on Assets (ROA) | -63.8% | -48.7% | -48.1% | -87.0% | -61.5% | -62.9% | -46.2% | -238.1% | -212.0% | -31.0% |
| Current Ratio | 8.39x | 6.36x | 5.57x | 2.14x | 3.56x | 3.81x | 22.83x | 22.11x | 3.40x | 4.56x |
| Quick Ratio | 7.07x | 5.54x | 4.91x | 1.51x | 3.28x | 3.34x | 22.03x | 22.02x | 3.37x | 4.52x |
| Debt to Equity | -- | -- | -- | 0.39x | 0.27x | 0.45x | 0.01x | -- | -- | -- |
| Revenue Growth (YoY) | -46.2% | +99.1% | -5.8% | -- | -100.0% | +134.5% | +3.5% | +12.5% | -- | -- |
| 5Y Revenue / Share Growth | +117.9% | +1469.4% | +248.4% | +117.3% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -304.0% | -363.5% | -368.7% | -303.3% | -237.5% | -168.7% |
| Net Profit Margin | -- | -- | -275.9% | -343.0% | -304.5% | -271.1% | -224.4% | -162.8% |
| Return on Equity (ROE) | -81.4% | -71.6% | -79.0% | -72.4% | -77.8% | -139.2% | -88.2% | -57.8% |
| Return on Assets (ROA) | -68.4% | -59.7% | -62.5% | -63.8% | -65.8% | -98.9% | -75.2% | -48.7% |
| Current Ratio | 6.26x | 6.03x | 4.79x | 8.39x | 6.50x | 3.45x | 6.79x | 6.36x |
| Quick Ratio | 4.53x | 4.68x | 4.10x | 7.07x | 5.26x | 2.45x | 5.47x | 5.54x |
| Revenue Growth (YoY) | -- | -- | +115.3% | -51.0% | -36.0% | -26.3% | -71.9% | +113.1% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -328.5% | -- | -- | -- |